Risks of Bleeding Recurrence and Cardiovascular Events With Continued Aspirin Use After Lower Gastrointestinal...

Area of Science:

• Gastroenterology
• Cardiology
• Clinical Medicine

Background:

• The decision to resume low-dose aspirin after lower gastrointestinal (GI) bleeding is complex.
• Patients face a potential trade-off between recurrent GI bleeding and cardiovascular protection.

Purpose of the Study:

• To assess the long-term risks of recurrent lower GI bleeding and serious cardiovascular outcomes in patients who resume aspirin after aspirin-associated lower GI bleeding.
• To compare outcomes between aspirin users and non-users following a lower GI bleeding event.

Main Methods:

• A retrospective study analyzed data from 295 patients with lower GI bleeding who were on aspirin.
• Outcomes (recurrent GI bleeding, cardiovascular events, death) were tracked over 5 years.
• Patients were categorized based on the duration of aspirin use during the follow-up period.

Main Results:

• Aspirin users had a significantly higher risk of recurrent lower GI bleeding (18.9%) compared to non-users (6.9%).
• Conversely, aspirin users experienced fewer serious cardiovascular events (22.8%) than non-users (36.5%).
• Aspirin use was also associated with a lower rate of death from other causes.

Conclusions:

• Continuation of aspirin after lower GI bleeding is linked to an increased risk of rebleeding.
• However, aspirin use also provides significant protection against serious cardiovascular events and overall mortality.
• The findings highlight a critical balance between GI bleeding risk and cardiovascular benefits when managing patients on aspirin post-GI bleed.